Annexon Stock

Annexon Current Liabilities

The Current Liabilities of Annexon (ANNX) as of Aug 9, 2026 is 42.63 M USD. In the previous year, Current Liabilities was 50.60 M USD — a change of -15.75% (lower).

Current Liabilities

42.63 MUSD

YoY

-15.75%

Last updated:

Current Liabilities of Annexon is 2026 42.63 M USD. Current Liabilities of Annexon was 2025 50.60 M USD. It decreases by -15.75% lower compared to the previous year.
Access this data via the Eulerpool API

Annexon Stock analysis

What does Annexon do? Annexon Inc is a biopharmaceutical company based in South San Francisco, California. It was founded in 2011 by Doug Love, Ted Love, and Arnon Rosenthal, who had previously worked at major pharmaceutical companies such as Genentech and Novartis. The company's main goal is to develop new treatment options for neurodegenerative diseases, focusing on the development of drugs that target the autophagy process in cells to reduce damage to nerve cells and alleviate symptoms. Annexon Inc has two divisions, Annexon Biosciences and Annexon Clinical, with partnerships with renowned pharmaceutical companies to advance drug development. Its main product is ANX005, a therapeutic antibody protein that targets the role of the complement system in neurodegenerative diseases. Annexon Inc has received multiple awards for its work and innovations and has a dedicated team of scientists and executives committed to improving the lives of people with neurodegenerative diseases. Annexon is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Annexon stock

Current Liabilities of Annexon is 42.63 M USD in 2026.

Current Liabilities of Annexon changed from 50.60 M USD to 42.63 M USD, representing a -15.75% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Annexon since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Annexon historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Annexon

All Key Metrics — Annexon